Literature DB >> 33538799

AKT: a key to RT?

Jennifer R Brown1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33538799      PMCID： PMC7869187          DOI： 10.1182/blood.2020008313

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


× No keyword cloud information.
  7 in total

1.  Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.

Authors:  Tiziana Vaisitti; Esteban Braggio; John N Allan; Francesca Arruga; Sara Serra; Alberto Zamò; Wayne Tam; Amy Chadburn; Richard R Furman; Silvia Deaglio
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 12.701

2.  Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.

Authors:  Inhye E Ahn; Chingiz Underbayev; Adam Albitar; Sarah E M Herman; Xin Tian; Irina Maric; Diane C Arthur; Laura Wake; Stefania Pittaluga; Constance M Yuan; Maryalice Stetler-Stevenson; Susan Soto; Janet Valdez; Pia Nierman; Jennifer Lotter; Liqiang Xi; Mark Raffeld; Mohammed Farooqui; Maher Albitar; Adrian Wiestner
Journal:  Blood       Date:  2017-01-03       Impact factor: 22.113

3.  Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma.

Authors:  Fabienne Lucas; Kerry A Rogers; Bonnie K Harrington; Rosa Lapalombella; Alexander Pan; Lianbo Yu; Justin Breitbach; Ralf Bundschuh; Virginia M Goettl; Zachary A Hing; Parviz Kanga; Rose Mantel; Deepa Sampath; Lisa L Smith; Ronni Wasmuth; Danielle K White; Pearlly Yan; John C Byrd; Jennifer A Woyach
Journal:  Clin Cancer Res       Date:  2019-07-11       Impact factor: 12.531

4.  Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.

Authors:  Vivien Kohlhaas; Stuart James Blakemore; Mona Al-Maarri; Nadine Nickel; Martin Pal; Andreas Roth; Nadine Hövelmeyer; Stephan C Schäfer; Gero Knittel; Philipp Lohneis; Milos Nikolic; Janica L Wiederstein; Marek Franitza; Theodoros Georgomonolis; Nina Reinart; Marco Herling; Carmen Herling; Elena M Hartmann; Andreas Rosenwald; Wolfram Klapper; Reinhard Büttner; Riccardo Moia; Davide Rossi; Renzo Boldorini; Gianluca Gaidano; Lukas P Frenzel; Hans Christian Reinhardt; Jens C Brüning; Michael Hallek; Marcus Krüger; Martin Peifer; Christian P Pallasch; F Thomas Wunderlich
Journal:  Blood       Date:  2021-02-04       Impact factor: 22.113

5.  Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.

Authors:  Giulia Fabbri; Hossein Khiabanian; Antony B Holmes; Jiguang Wang; Monica Messina; Charles G Mullighan; Laura Pasqualucci; Raul Rabadan; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2013-10-14       Impact factor: 14.307

6.  Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia.

Authors:  Gero Knittel; Tim Rehkämper; Darya Korovkina; Paul Liedgens; Christian Fritz; Alessandro Torgovnick; Yussor Al-Baldawi; Mona Al-Maarri; Yupeng Cun; Oleg Fedorchenko; Arina Riabinska; Filippo Beleggia; Phuong-Hien Nguyen; F Thomas Wunderlich; Monika Ortmann; Manuel Montesinos-Rongen; Eugen Tausch; Stephan Stilgenbauer; Lukas P Frenzel; Marco Herling; Carmen Herling; Jasmin Bahlo; Michael Hallek; Martin Peifer; Reinhard Buettner; Thorsten Persigehl; H Christian Reinhardt
Journal:  Nat Commun       Date:  2017-07-28       Impact factor: 14.919

Review 7.  Current trends in the management of Richter's syndrome.

Authors:  John N Allan; Richard R Furman
Journal:  Int J Hematol Oncol       Date:  2019-01-08
  7 in total
  1 in total

Review 1.  Targeting metabolic reprogramming in chronic lymphocytic leukemia.

Authors:  Yu Nie; Xiaoya Yun; Ya Zhang; Xin Wang
Journal:  Exp Hematol Oncol       Date:  2022-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.